Public, NASDAQ:VIAP
NASDAQ Capital Market
Emergent Biosolutions spent $550K lobbying in 1Q and VIA Pharmaceuticals Set to Join Russell Microcap Index
Date: Mon, 30 Jun 2008 13:23:13 GMT
Tags:
Emergent Biosolutions spent $550K lobbying in 1Q and VIA Pharmaceuticals Set to Join Russell Microcap Index
Financial News USA (press release) - Jun 30, 2008
Financial News USA (press release) - Jun 30, 2008
City of Industry , CA - - ( www.FinancialNewsUSA . com ) - - 06 / 30 / 2008 - Healthcare industry news provided by Financial News USA ( OTC : FNWU ).Biopharmaceutical company Emergent BioSolutions ...
VIA Pharmaceuticals Set to Join Russell Microcap Index
Date: Fri, 27 Jun 2008 19:39:28 GMT
Tags:
VIA Pharmaceuticals Set to Join Russell Microcap Index
FOXBusiness - Jun 27, 2008
FOXBusiness - Jun 27, 2008
SAN FRANCISCO , June 27 , 2008 / PRNewswire - FirstCall via COMTEX / - - - - VIA Pharmaceuticals , Inc . ( Nasdaq : VIAP ) , a biotechnology company focused on the development of compounds for ...
Exelixis and GlaxoSmithKline Agree to Successfully Conclude Six-Year Discovery and Development Collaboration and VIA Pharmaceuticals Set to Join Russell Microcap Index
Date: Fri, 27 Jun 2008 14:33:28 GMT
Tags:
Exelixis and GlaxoSmithKline Agree to Successfully Conclude Six-Year Discovery and Development Collaboration and VIA Pharmaceuticals Set to Join Russell Microcap Index
Financial News USA (press release) - Jun 27, 2008
Financial News USA (press release) - Jun 27, 2008
City of Industry , CA - - ( www.FinancialNewsUSA . com ) - - 06 / 27 / 2008 - Healthcare industry news provided by Financial News USA ( OTC : FNWU ).Exelixis , Inc . ( NASDAQ : EXEL ) announced ...
VIA Pharmaceuticals to Present at Seventh Annual Needham & Company Biotechnology and Medical Technology Conference
Date: Tue, 03 Jun 2008 12:47:37 GMT
Tags:
VIA Pharmaceuticals to Present at Seventh Annual Needham & Company Biotechnology and Medical Technology Conference
Earthtimes (press release) - Jun 3, 2008
Earthtimes (press release) - Jun 3, 2008
SAN FRANCISCO , June 3 - - VIA Pharmaceuticals ( Nasdaq : VIAP ) , a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease , announced today ...
VIA Pharmaceuticals Completes Phase II Enrollment
Date: Wed, 21 May 2008 14:56:25 GMT
Tags:
VIA Pharmaceuticals Completes Phase II Enrollment
FDA news (subscription) - May 21, 2008
FDA news (subscription) - May 21, 2008
The study has enrolled 191 patients in the second of three Phase II trials investigating VIA - 2291 , the company's candidate for cardiovascular disease.The candidate is a potent , small molecule ...
VIA Pharmaceuticals Set to Join Russell Microcap Index (PR Newswire)
Date: Fri, 27 Jun 2008 12:30:00 Etc/GMT
Tags:
VIA Pharmaceuticals, Inc. , a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, will join the Russell Microcap Index when Russell Investments reconstitutes its family of U.S. indexes on June 27 after market close, according to a preliminary list of additions posted on http://www.russell.com
VIA Pharmaceuticals to Present at Seventh Annual Needham & Company Biotechnology and Medical Technology Conference (PR Newswire)
Date: Tue, 3 Jun 2008 12:30:00 Etc/GMT
Tags:
VIA Pharmaceuticals , a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, announced today that Lawrence K. Cohen, PhD, president and chief executive officer of VIA, and James G.
VIA PHARMACEUTICALS, INC. Financials (EDGAR Online Financials)
Date: Thu, 22 May 2008 13:28:10 Etc/GMT
Tags:
VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial (PR Newswire)
Date: Thu, 15 May 2008 12:30:00 Etc/GMT
Tags:
VIA Pharmaceuticals, Inc. , a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, announced today that it has completed patient enrollment in its acute coronary syndrome study.
VIA PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure (EDGAR Online)
Date: Wed, 14 May 2008 17:59:04 Etc/GMT
Tags: